Scott T. Pierce
Medical Practice in Lexington, KY
License number
Kentucky 26702
Issued Date
Jul 1, 1989
Expiration Date
Feb 28, 2018
Category
Hematology/Oncology
Type
Hospital Based
Address
Address
701 Bob-O-Link Dr #100, Lexington, KY 40504
Education
University of Illinois College of Medicine, Peoria, 1988
Phone
(859) 224-3194 (Work)
Personal information
See more information about Scott T. Pierce at radaris.comName
Address
Phone
541 Oaks Rd, Jamestown, KY 42629
3311 Georgetown Rd, Paris, KY 40361
Organization information
See more information about Scott T. Pierce at bizstanding.comScott T Pierce
701 Bob O Link Dr, Lexington, KY 40504
Industry:
Medical Doctor's Office
Oncologys:
Scott T Pierce (Medical Doctor, Principal),Bluegrass Hematology Oncology P.s.c Oncology, inactive
St Joseph Hematology - Scott T Pierce MD
701 Bob O Link Dr STE 100, Lexington, KY 40504
Categories:
Hematology Physicians & Surgeons, Medical Research & Development, Oncology Physicians & Surgeons, ...
Site:
Phone:
(859) 224-3194 (Phone)
Products:
Hematology Oncology
Professional information
See more information about Scott T. Pierce at trustoria.com
Dr. Scott T Pierce, Lexington KY - MD (Doctor of Medicine)
Dr. Scott T Pierce, Lexington KY - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Saint Joseph Hematology/Oncology
701 Bob O Link Dr SUITE 100, Lexington 40504
(859) 224-3194 (Phone)
701 Bob O Link Dr SUITE 100, Lexington 40504
(859) 224-3194 (Phone)
Certifications:
Hematology, 2004, Internal Medicine, 2011, Medical Oncology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Saint Joseph Hematology/Oncology
701 Bob O Link Dr SUITE 100, Lexington 40504
Clark Regional Medical Center
175 Hospital Dr, Winchester 40391
Saint Joseph East
150 North Eagle Creek Dr, Lexington 40509
Saint Joseph Hospital
1 Saint Joseph Dr, Lexington 40504
701 Bob O Link Dr SUITE 100, Lexington 40504
Clark Regional Medical Center
175 Hospital Dr, Winchester 40391
Saint Joseph East
150 North Eagle Creek Dr, Lexington 40509
Saint Joseph Hospital
1 Saint Joseph Dr, Lexington 40504
Education:
Medical School
University Of Illinois College Of Medicine Chicago
Graduated: 1988
University Of Illinois College Of Medicine Chicago
Graduated: 1988
Scott T Pierce, Lexington KY
Scott T Pierce, Lexington KY
Specialties:
Hematologist
Address:
701 Bob O Link Dr, Lexington, KY 40504
Education:
University of Illinois, College of Medicine - Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)*, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)*
Partner, Rood And Riddle Equine Hospital
Partner, Rood And Riddle Equine Hospital
Position:
Partner at Rood and Riddle Equine, Ambulatory veterinarian at Rood and Riddle Equine Hospital
Location:
Lexington, Kentucky Area
Industry:
Veterinary
Work:
Rood and Riddle Equine
since 1989
-
Partner
Rood and Riddle Equine Hospital
since 1985
-
Ambulatory veterinarian
Education:
University of Missouri-Columbia 1979 - 1983
DVM, Veterinary Medicine
DVM, Veterinary Medicine
Scott Pierce, Lexington KY
Scott Pierce, Lexington KY
Work:
Bluegrass Hematology/Oncology
701 Bob O Link Dr, Lexington, KY 40504 Saint Joseph Hematolgoy/Oncology Associates
701 Bob-O-Link Dr, Lexington, KY 40504 St Joseph Hematology Oncology
170 Pedro Way, Winchester, KY 40391 Saint Joseph Hospital
1 Saint Joseph Dr, Lexington, KY 40504
701 Bob O Link Dr, Lexington, KY 40504 Saint Joseph Hematolgoy/Oncology Associates
701 Bob-O-Link Dr, Lexington, KY 40504 St Joseph Hematology Oncology
170 Pedro Way, Winchester, KY 40391 Saint Joseph Hospital
1 Saint Joseph Dr, Lexington, KY 40504
Ceo At Ha Concepts Inc
Ceo At Ha Concepts Inc
Position:
CEO at HA Concepts Inc
Location:
Lexington, Kentucky Area
Industry:
Health, Wellness and Fitness
Work:
HA Concepts Inc
-
CEO
Chondroprotective/Restorative Compositions And Methods Of Use Thereof
Chondroprotective/Restorative Compositions And Methods Of Use Thereof
US Patent:
2005018, Aug 18, 2005
Filed:
Apr 1, 2005
Appl. No.:
11/095632
Inventors:
Scott Pierce - Lexington KY, US
International Classification:
A61K031/739, A61K031/7008
US Classification:
514054000, 514062000
Abstract:
The instant invention provides a method of treating or preventing osteoarthritis, joint effusion, joint inflammation and pain, synovitis, lameness, post operative arthroscopic surgery, deterioration of proper joint function including joint mobility, the reduction or inhibition of metabolic activity of chondrocytes, the activity of enzymes that degrade cartilage, the reduction or inhibition of the production of Hyaluronic acid, said method comprising orally administering to a mammalian species a therapeutically effective amount of Hyaluronic Acid or pharmaceutically acceptable salts thereof. Additionally, compositions containing hyaluronic acid; chondroitin sulfate, and glucosamine sulfate in a paste formulation are also disclosed which can be administered on their own or can be used as a feed additive.
Chondroprotective/Restorative Compositions And Methods Of Use Thereof
Chondroprotective/Restorative Compositions And Methods Of Use Thereof
US Patent:
6924273, Aug 2, 2005
Filed:
Oct 2, 2001
Appl. No.:
09/967977
Inventors:
Scott W. Pierce - Lexington KY, US
International Classification:
A01N065/00, A61K031/73, A61K038/16
US Classification:
514 54, 514 2, 514 56, 514 62, 424423, 4241341, 424450, 424484, 424756, 424499, 424548, 424639, 424486, 424488, 536 21, 536 54, 536 187, 536 551, 536 552
Abstract:
The instant invention provides a method of treating or preventing osteoarthritis, joint effusion, joint inflammation and pain, synovitis, lameness, post operative arthroscopic surgery, deterioration of proper joint function including joint mobility, the reduction or inhibition of metabolic activity of chondrocytes, the activity of enzymes that degrade cartilage, the reduction or inhibition of the production of Hyaluronic acid, said method comprising orally administering to a mammalian species a therapeutically effective amount of Hyaluronic Acid or pharmaceutically acceptable salts thereof. Additionally, compositions containing hyaluronic acid; chondroitin sulfate, and glucosamine sulfate in a paste formulation are also disclosed which can be administered on their own or can be used as a feed additive.